Regenxbio Historical Balance Sheet

RGNX Stock

USD 7.37 0.22 3.08%

Trend analysis of Regenxbio balance sheet accounts such as Total Stockholder Equity of 348.3 M, Current Deferred Revenue of 161.7 K, Net Debt of 51.8 M or Accounts Payable of 27.5 M provides information on Regenxbio's total assets, liabilities, and equity, which is the actual value of Regenxbio to its prevalent stockholders. By breaking down trends over time using Regenxbio balance sheet statements, investors will see what precisely the company owns and what it owes to creditors or other parties at the end of each accounting year.

Cash Flow Balance Sheet Income Statement

Yuan Drop

Covid

Financial Statement Analysis is much more than just reviewing and examining Regenxbio latest accounting reports to predict its past. Macroaxis encourages investors to analyze financial statements over time for various trends across multiple indicators and accounts to determine whether Regenxbio is a good buy for the upcoming year.

Regenxbio Inventory

16.78 Million

Check out Your Equity Center to better understand how to build diversified portfolios, which includes a position in Regenxbio. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in board of governors.

For more information on how to buy Regenxbio Stock please use our How to Invest in Regenxbio guide.

About Regenxbio Balance Sheet Analysis

Balance Sheet is a snapshot of the financial position of Regenxbio at a specified time, usually calculated after every quarter, six months, or one year. Regenxbio Balance Sheet has two main parts: assets and liabilities. Liabilities are the debts or obligations of Regenxbio and are divided into current liabilities and long term liabilities. An asset, on the other hand, is anything of value that can be converted into cash and which Regenxbio currently owns. An asset can also be divided into two categories, current and non-current.

Regenxbio Balance Sheet Chart

At this time, Regenxbio's Property Plant And Equipment Net is fairly stable compared to the past year. Property Plant And Equipment Gross is likely to rise to about 301.6 M in 2025, whereas Total Assets are likely to drop slightly above 487 M in 2025.

Total Assets Short Long Term Debt Total Other Current Liab Total Current Liabilities Cash And Short Term Investments Inventory

Add Fundamental

Total Assets

Total assets refers to the total amount of Regenxbio assets owned. Assets are items that have some economic value and are expended over time to create a benefit for the owner. These assets are usually recorded in Regenxbio books under different categories such as cash, marketable securities, accounts receivable,prepaid expenses, inventory, fixed assets, intangible assets, other assets, marketable securities, accounts receivable, prepaid expenses and others. The total value of all owned resources that are expected to provide future economic benefits to the business, including cash, investments, accounts receivable, inventory, property, plant, equipment, and intangible assets.

Total Current Liabilities

Total Current Liabilities is an item on Regenxbio balance sheet that include short term debt, accounts payable, accrued salaries payable, payroll taxes payable, accrued liabilities and other debts. Total Current Liabilities of Regenxbio are important to investors because some useful performance ratios such as Current Ratio and Quick Ratio require Total Current Liabilities to be accurate. The total amount of liabilities that a company is expected to pay within one year, including debts, accounts payable, and other short-term financial obligations.

Cash And Short Term Investments

Short Term Investments is an account in the current assets section of Regenxbio balance sheet. This account contains Regenxbio investments that will expire within one year. These investments include stocks and bonds that can be liquidated by Regenxbio fairly quickly. The sum of a company's cash on hand, including bank deposits and short-term, highly liquid investments that are easily convertible to known amounts of cash.

Most accounts from Regenxbio's balance sheet are interrelated and interconnected. However, analyzing balance sheet accounts one by one will only give a small insight into Regenxbio current financial condition. On the other hand, looking into the entire matrix of balance sheet accounts, and analyzing their relationships over time can provide a more complete picture of the company financial strength now and in the future. Check out Your Equity Center to better understand how to build diversified portfolios, which includes a position in Regenxbio. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in board of governors.

For more information on how to buy Regenxbio Stock please use our How to Invest in Regenxbio guide.At this time, Regenxbio's Property Plant And Equipment Net is fairly stable compared to the past year. Property Plant And Equipment Gross is likely to rise to about 301.6 M in 2025, whereas Total Assets are likely to drop slightly above 487 M in 2025.

	2022	2023	2024	2025 (projected)
Short and Long Term Debt Total	94.8M	89.3M	102.7M	107.8M
Total Assets	833.3M	574.0M	660.1M	487.0M

Short Long Term Debt Total Total Assets

Regenxbio balance sheet Correlations

	Total Assets	Short Long Term Debt Total	Other Current Liab	Total Current Liabilities	Total Stockholder Equity	Current Deferred Revenue	Net Debt	Retained Earnings	Accounts Payable	Cash	Non Current Assets Total	Cash And Short Term Investments	Net Receivables	Common Stock Total Equity	Common Stock Shares Outstanding	Other Current Assets	Other Stockholder Equity	Total Liab	Total Current Assets	Short Term Debt	Common Stock	Net Tangible Assets	Non Currrent Assets Other	Other Assets	Short Term Investments	Inventory
Total Assets		0.8	0.79	0.8	0.96	0.71	-0.49	-0.58	0.7	0.75	0.95	0.96	0.85	-0.64	0.88	0.72	0.85	0.86	0.97	0.69	-0.64	0.96	0.69	0.58	0.69	0.9
Short Long Term Debt Total	0.8		0.99	0.99	0.64	0.31	-0.08	-0.88	0.94	0.46	0.77	0.74	0.74	-0.48	0.79	0.96	0.92	0.98	0.77	0.83	-0.48	0.76	0.39	0.31	0.64	0.95
Other Current Liab	0.79	0.99		1.0	0.66	0.33	-0.04	-0.89	0.94	0.42	0.78	0.73	0.72	-0.49	0.81	0.99	0.94	0.95	0.75	0.79	-0.49	0.78	0.42	0.35	0.66	0.96
Total Current Liabilities	0.8	0.99	1.0		0.67	0.36	-0.03	-0.89	0.95	0.41	0.79	0.73	0.73	-0.49	0.81	0.98	0.94	0.95	0.76	0.81	-0.49	0.79	0.43	0.33	0.68	0.97
Total Stockholder Equity	0.96	0.64	0.66	0.67		0.81	-0.51	-0.44	0.57	0.7	0.92	0.93	0.76	-0.67	0.83	0.6	0.78	0.71	0.92	0.56	-0.67	0.96	0.77	0.59	0.67	0.81
Current Deferred Revenue	0.71	0.31	0.33	0.36	0.81		-0.5	-0.13	0.25	0.57	0.71	0.67	0.64	-0.57	0.59	0.26	0.48	0.39	0.67	0.31	-0.57	0.7	0.45	0.6	0.42	0.52
Net Debt	-0.49	-0.08	-0.04	-0.03	-0.51	-0.5		-0.27	0.19	-0.92	-0.41	-0.56	-0.44	0.24	-0.21	0.08	-0.06	-0.28	-0.53	0.1	0.24	-0.35	-0.29	-0.62	0.13	-0.21
Retained Earnings	-0.58	-0.88	-0.89	-0.89	-0.44	-0.13	-0.27		-0.95	-0.1	-0.5	-0.57	-0.61	0.49	-0.76	-0.9	-0.88	-0.78	-0.6	-0.81	0.49	-0.63	-0.32	0.06	-0.74	-0.82
Accounts Payable	0.7	0.94	0.94	0.95	0.57	0.25	0.19	-0.95		0.2	0.66	0.65	0.65	-0.49	0.79	0.94	0.93	0.87	0.68	0.9	-0.49	0.71	0.4	0.07	0.77	0.89
Cash	0.75	0.46	0.42	0.41	0.7	0.57	-0.92	-0.1	0.2		0.67	0.78	0.68	-0.39	0.49	0.3	0.4	0.63	0.77	0.24	-0.39	0.6	0.41	0.67	0.14	0.55
Non Current Assets Total	0.95	0.77	0.78	0.79	0.92	0.71	-0.41	-0.5	0.66	0.67		0.84	0.71	-0.54	0.79	0.72	0.78	0.81	0.84	0.66	-0.54	0.91	0.59	0.7	0.58	0.87
Cash And Short Term Investments	0.96	0.74	0.73	0.73	0.93	0.67	-0.56	-0.57	0.65	0.78	0.84		0.88	-0.68	0.88	0.64	0.83	0.82	1.0	0.65	-0.68	0.92	0.74	0.43	0.71	0.85
Net Receivables	0.85	0.74	0.72	0.73	0.76	0.64	-0.44	-0.61	0.65	0.68	0.71	0.88		-0.51	0.81	0.64	0.77	0.81	0.9	0.63	-0.51	0.8	0.53	0.31	0.68	0.78
Common Stock Total Equity	-0.64	-0.48	-0.49	-0.49	-0.67	-0.57	0.24	0.49	-0.49	-0.39	-0.54	-0.68	-0.51		-0.65	-0.45	-0.64	-0.48	-0.67	-0.56	1.0	-0.7	-0.48	-0.16	-0.55	-0.59
Common Stock Shares Outstanding	0.88	0.79	0.81	0.81	0.83	0.59	-0.21	-0.76	0.79	0.49	0.79	0.88	0.81	-0.65		0.76	0.92	0.79	0.9	0.74	-0.65	0.92	0.68	0.31	0.86	0.89
Other Current Assets	0.72	0.96	0.99	0.98	0.6	0.26	0.08	-0.9	0.94	0.3	0.72	0.64	0.64	-0.45	0.76		0.92	0.9	0.68	0.74	-0.45	0.75	0.38	0.31	0.65	0.94
Other Stockholder Equity	0.85	0.92	0.94	0.94	0.78	0.48	-0.06	-0.88	0.93	0.4	0.78	0.83	0.77	-0.64	0.92	0.92		0.88	0.85	0.79	-0.64	0.88	0.61	0.27	0.82	0.96
Total Liab	0.86	0.98	0.95	0.95	0.71	0.39	-0.28	-0.78	0.87	0.63	0.81	0.82	0.81	-0.48	0.79	0.9	0.88		0.84	0.78	-0.48	0.78	0.43	0.41	0.59	0.94
Total Current Assets	0.97	0.77	0.75	0.76	0.92	0.67	-0.53	-0.6	0.68	0.77	0.84	1.0	0.9	-0.67	0.9	0.68	0.85	0.84		0.67	-0.67	0.93	0.72	0.43	0.73	0.87
Short Term Debt	0.69	0.83	0.79	0.81	0.56	0.31	0.1	-0.81	0.9	0.24	0.66	0.65	0.63	-0.56	0.74	0.74	0.79	0.78	0.67		-0.56	0.66	0.37	0.0	0.77	0.75
Common Stock	-0.64	-0.48	-0.49	-0.49	-0.67	-0.57	0.24	0.49	-0.49	-0.39	-0.54	-0.68	-0.51	1.0	-0.65	-0.45	-0.64	-0.48	-0.67	-0.56		-0.7	-0.48	-0.16	-0.55	-0.59
Net Tangible Assets	0.96	0.76	0.78	0.79	0.96	0.7	-0.35	-0.63	0.71	0.6	0.91	0.92	0.8	-0.7	0.92	0.75	0.88	0.78	0.93	0.66	-0.7		0.74	0.51	0.78	0.89
Non Currrent Assets Other	0.69	0.39	0.42	0.43	0.77	0.45	-0.29	-0.32	0.4	0.41	0.59	0.74	0.53	-0.48	0.68	0.38	0.61	0.43	0.72	0.37	-0.48	0.74		0.21	0.74	0.54
Other Assets	0.58	0.31	0.35	0.33	0.59	0.6	-0.62	0.06	0.07	0.67	0.7	0.43	0.31	-0.16	0.31	0.31	0.27	0.41	0.43	0.0	-0.16	0.51	0.21		-0.06	0.47
Short Term Investments	0.69	0.64	0.66	0.68	0.67	0.42	0.13	-0.74	0.77	0.14	0.58	0.71	0.68	-0.55	0.86	0.65	0.82	0.59	0.73	0.77	-0.55	0.78	0.74	-0.06		0.7
Inventory	0.9	0.95	0.96	0.97	0.81	0.52	-0.21	-0.82	0.89	0.55	0.87	0.85	0.78	-0.59	0.89	0.94	0.96	0.94	0.87	0.75	-0.59	0.89	0.54	0.47	0.7

Click cells to compare fundamentals

Regenxbio Account Relationship Matchups

Regenxbio balance sheet Accounts

	2020	2021	2022	2023	2024	2025 (projected)
Total Assets	708.2M	1.1B	833.3M	574.0M	660.1M	487.0M
Short Long Term Debt Total	72.7M	86.7M	94.8M	89.3M	102.7M	107.8M
Other Current Liab	62.2M	100.9M	89.4M	100.3M	115.3M	121.1M
Total Current Liabilities	81.4M	130.5M	130.4M	130.3M	149.8M	157.3M
Total Stockholder Equity	377.8M	764.3M	516.2M	311.7M	358.5M	348.3M
Net Debt	(265.8M)	(258.5M)	(2.2M)	54.8M	49.3M	51.8M
Retained Earnings	(289.1M)	(161.2M)	(441.6M)	(705.0M)	(634.5M)	(602.8M)
Accounts Payable	10.6M	11.4M	27.2M	22.8M	26.2M	27.5M
Cash	338.4M	345.2M	97.0M	34.5M	39.7M	37.7M
Non Current Assets Total	177.0M	595.1M	417.3M	239.0M	274.8M	200.1M
Cash And Short Term Investments	475.7M	457.4M	364.6M	275.3M	316.5M	255.6M
Net Receivables	43.0M	32.4M	28.1M	26.3M	30.3M	18.3M
Common Stock Shares Outstanding	37.3M	43.9M	43.2M	43.7M	50.3M	33.3M
Liabilities And Stockholders Equity	708.2M	1.1B	833.3M	574.0M	660.1M	487.0M
Other Current Assets	12.5M	28.9M	23.3M	33.4M	38.4M	40.3M
Other Stockholder Equity	667.2M	928.1M	973.1M	1.0B	1.2B	1.2B
Total Liab	330.4M	349.6M	317.1M	262.2M	301.6M	316.6M
Total Current Assets	531.2M	518.8M	416.0M	335.0M	385.2M	286.9M
Accumulated Other Comprehensive Income	(360K)	(2.6M)	(15.4M)	(4.4M)	(4.0M)	(3.8M)
Short Term Debt	5M	3.5M	12.0M	7.1M	8.1M	5.2M
Net Tangible Assets	450.2M	377.8M	764.3M	516.2M	593.6M	386.3M
Non Currrent Assets Other	9.9M	10.7M	9.9M	7.5M	8.7M	8.4M
Other Assets	10.0M	8.8M	1.1B	9.9M	11.4M	10.8M
Short Term Investments	137.3M	112.2M	267.7M	240.7M	276.8M	168.1M
Inventory	6.5M	10.5M	18.8M	13.9M	16.0M	16.8M
Long Term Investments	50.1M	394.2M	200.6M	38.9M	44.7M	42.5M
Property Plant Equipment	39.1M	56.5M	192.5M	206.8M	237.8M	249.7M
Other Liab	5.2M	178.8M	134.2M	97.8M	112.5M	58.5M
Property Plant And Equipment Net	120.3M	192.5M	206.8M	192.6M	221.5M	232.6M
Retained Earnings Total Equity	(83.0M)	(177.8M)	(289.1M)	(161.2M)	(145.1M)	(152.4M)
Non Current Liabilities Total	249.0M	219.1M	186.6M	132.0M	151.7M	99.8M
Capital Surpluse	592.6M	627.8M	667.2M	928.1M	1.1B	586.6M
Property Plant And Equipment Gross	120.3M	192.5M	206.8M	249.8M	287.3M	301.6M
Net Invested Capital	377.8M	764.3M	516.2M	311.7M	358.5M	489.0M
Net Working Capital	449.8M	388.4M	285.5M	204.7M	235.4M	331.4M
Capital Lease Obligations	72.7M	86.7M	94.8M	89.3M	102.7M	66.1M

Also Currently Popular

Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.

BTC	Bitcoin
TRX	TRON
BNB	Binance Coin

Additional Tools for Regenxbio Stock Analysis

When running Regenxbio's price analysis, check to measure Regenxbio's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Regenxbio is operating at the current time. Most of Regenxbio's value examination focuses on studying past and present price action to predict the probability of Regenxbio's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Regenxbio's price. Additionally, you may evaluate how the addition of Regenxbio to your portfolios can decrease your overall portfolio volatility.

Macroaxis helps investors of all levels and skills to maximize the upside of all their holdings and minimize the risk associated with market volatility, economic swings, and company-specific events. View terms and conditions

Feedback Blog

Made with optimal in San Francisco

2024 Macroaxis LLC

Regenxbio Historical Balance Sheet

Regenxbio Inventory

16.78 Million

About Regenxbio Balance Sheet Analysis

Regenxbio Balance Sheet Chart

Total Assets

Total Current Liabilities

Cash And Short Term Investments

Regenxbio balance sheet Correlations

Regenxbio Account Relationship Matchups

High Positive Relationship

High Negative Relationship

Regenxbio balance sheet Accounts

Also Currently Popular

Additional Tools for Regenxbio Stock Analysis

COMMON DESTINATIONS

MAIN CATEGORIES

COMPANY

Total Current Liabilities	+ 1.0	Other Current Liab
Total Current Assets	+ 1.0	Cash And Short Term Investments
Common Stock	+ 1.0	Common Stock Total Equity
Other Current Liab	+ 0.99	Short Long Term Debt Total
Total Current Liabilities	+ 0.99	Short Long Term Debt Total
Other Current Assets	+ 0.99	Other Current Liab

Accounts Payable	- 0.95	Retained Earnings
Cash	- 0.92	Net Debt
Other Current Assets	- 0.9	Retained Earnings
Retained Earnings	- 0.89	Total Current Liabilities
Retained Earnings	- 0.89	Other Current Liab
Other Stockholder Equity	- 0.88	Retained Earnings